Huadong Li

Also affiliated with Nanjing Tech University, East China University of Science and Technology, Chongqing University, Hebei North University, Shanghai Jiao Tong University, Guangdong Pharmaceutical University, Chinese Academy of Sciences, Renji Hospital, Linyi People's Hospital, Shanghai Advanced Research Institute, Wuhan Union Hospital, The Synergetic Innovation Center for Advanced Materials, Union Hospital, Huazhong University of Science and Technology

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial”.

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

The Lancet(2020)10.1016/s0140-6736(20)31022-9

N/A

11.3DataRank · unranked

3663 citations

Dingyu Zhang, Guanhua Du, Ronghui Du, Jianping Zhao, Yang Jin +41 more

The Effects of ATIR Blocker on the Severity of COVID-19 in Hypertensive Inpatients and Virulence of SARS-CoV-2 in Hypertensive hACE2 Transgenic Mice

Journal of Cardiovascular Translational Research(2022)10.1007/s12265-021-10147-3

N/A

0DataRank · unranked

5 citations

Huadong Li, Yong Liu, Linlin Bao, Lingjun Zhan, Hong Gao +15 more